South Korea
· Delayed Price · Currency is KRW HLscience Statistics
Total Valuation
HLscience has a market cap or net worth of KRW 62.80 billion. The enterprise value is 35.72 billion.
| Market Cap | 62.80B |
| Enterprise Value | 35.72B |
Important Dates
The next estimated earnings date is Friday, November 15, 2024.
| Earnings Date | Nov 15, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
HLscience has 5.09 million shares outstanding. The number of shares has decreased by -1.16% in one year.
| Shares Outstanding | 5.09M |
| Shares Change (YoY) | -1.16% |
| Shares Change (QoQ) | -0.35% |
| Owned by Insiders (%) | 66.97% |
| Owned by Institutions (%) | n/a |
| Float | 1.68M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.85 |
| PB Ratio | 0.63 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -10.28 |
| EV / Sales | 1.62 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -6.39 |
Financial Position
The company has a current ratio of 14.58, with a Debt / Equity ratio of 0.45.
| Current Ratio | 14.58 |
| Quick Ratio | 12.17 |
| Debt / Equity | 0.45 |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.08 |
| Interest Coverage | -1,472.51 |
Financial Efficiency
Return on equity (ROE) is -3.51% and return on invested capital (ROIC) is -4.27%.
| Return on Equity (ROE) | -3.51% |
| Return on Assets (ROA) | -4.15% |
| Return on Capital (ROIC) | -4.27% |
| Revenue Per Employee | 310.60M |
| Profits Per Employee | -48.95M |
| Employee Count | 71 |
| Asset Turnover | 0.21 |
| Inventory Turnover | 1.75 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -15.16% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -15.16% |
| 50-Day Moving Average | 12,835.40 |
| 200-Day Moving Average | 14,423.80 |
| Relative Strength Index (RSI) | 48.41 |
| Average Volume (20 Days) | 70,167 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HLscience had revenue of KRW 22.05 billion and -3.48 billion in losses. Loss per share was -681.96.
| Revenue | 22.05B |
| Gross Profit | 13.26B |
| Operating Income | -6.95B |
| Pretax Income | -4.96B |
| Net Income | -3.48B |
| EBITDA | -4.46B |
| EBIT | -6.95B |
| Loss Per Share | -681.96 |
Balance Sheet
The company has 27.62 billion in cash and 450.00 million in debt, giving a net cash position of 27.17 billion or 5,335.41 per share.
| Cash & Cash Equivalents | 27.62B |
| Total Debt | 450.00M |
| Net Cash | 27.17B |
| Net Cash Per Share | 5,335.41 |
| Equity (Book Value) | 99.62B |
| Book Value Per Share | 19,572.60 |
| Working Capital | 34.42B |
Cash Flow
In the last 12 months, operating cash flow was -4.42 billion and capital expenditures -1.17 billion, giving a free cash flow of -5.59 billion.
| Operating Cash Flow | -4.42B |
| Capital Expenditures | -1.17B |
| Free Cash Flow | -5.59B |
| FCF Per Share | -1,097.47 |
Margins
Gross margin is 60.13%, with operating and profit margins of -31.50% and -15.76%.
| Gross Margin | 60.13% |
| Operating Margin | -31.50% |
| Pretax Margin | -22.50% |
| Profit Margin | -15.76% |
| EBITDA Margin | -20.21% |
| EBIT Margin | -31.50% |
| FCF Margin | -25.35% |
Dividends & Yields
HLscience does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.16% |
| Shareholder Yield | 1.16% |
| Earnings Yield | -5.53% |
| FCF Yield | -8.90% |
Stock Splits
The last stock split was on December 29, 2020. It was a forward split with a ratio of 1.05.
| Last Split Date | Dec 29, 2020 |
| Split Type | Forward |
| Split Ratio | 1.05 |